bio-key.com (BKYI) Company Total Revenue

BIO-key - graphic logo of issuer BKYI

BIO-key International is implementing AI platforms for access automation, which strengthens the demand for biometrics amid rising global cyber threats. The company's commercial revenue confirms this trend, with current levels sitting around 0.01. Positive sales momentum is supported by an expanding client base in the education and corporate sectors, which will ensure stable business growth.

BKYI - BIO-key International, Inc. Revenue and Sales Volume over the range 07/04/2022 - 11/18/2026

Analytical breakdowns for BIO-key International (BKYI)

- stock price and consensus target price:
Comprehensive company analysis:BKYI, BIO-key International, Inc.
Original product of BIO-key

BIO-key International (BKYI) monetizes unique biometric patents amid stringent US government regulation, creating high barriers to entry for competitors. An analysis of the company's historical sales levels captures confirmed cash inflows, allowing investors to assess the real liquidity of the business model and avoid overpaying for the asset by comparing actual revenue volume with potential yield and the reliability of fundamental indicators.